• Loading stock data…

Pluristyx, panCELLa, and Implant Therapeutics Announce a Strategic Alliance to Manufacture and Distribute Genetically Modified, Clinical-grade Human-induced Pluripotent Stem Cells

[#item_full_content]

Print Friendly, PDF & Email
Spread the word